Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-21-1914
Abstract: Purpose: Activation of STING (stimulator of interferon genes) can trigger a robust, innate antitumor immune response in immunologically “cold” tumors such as glioblastoma. Patients and Methods: A small-molecule STING agonist, IACS-8779, was stereotactically administered using… read more here.
Keywords: results clinical; sting agonist; intratumoral delivery; delivery sting ... See more keywords